CD5 Immunoreactivity Is Associated With Longer Overall Survival in Thymic Carcinoma: A Brief Report by Julia R. Naso, MD, PhD, Sarah M. Jenkins, MS, Julie A. Vrana, PhD, Justin W. Koepplin, HTL (ASCP), Kenneth R. Olivier, MD, Stephen D. Cassivi, MD, Julian R. Molina, MD, PhD, Anja C. Roden, MD

Get full text